LENSAR sets up next earnings date, shares trade in a tight Nasdaq range

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 21:29.

LENSAR Inc. (US52633C1071) is drawing attention on Nasdaq as investors look ahead to the next earnings update and weigh the stock’s low-earnings multiple against its medical device peers in the healthcare equipment space on the U.S. market. MarketBeat data on LENSAR earnings

What recent data show on LNSR

On Nasdaq, LENSAR shares last closed at around 5.64 to 5.66 U.S. dollars on 22 June, with after-hours indications near 5.70 dollars according to U.S. trading records. MarketBeat price overview for LNSR A separate technical snapshot cites a last trade at 5.635 dollars, down 1.83 percent on that session, and a market capitalization of roughly 68.5 million dollars in the healthcare equipment and supplies industry. TradingKey technical view on LENSAR

Technical indicators compiled by one analytics platform point to a short-term sell signal, with zero buy and three sell signals across its indicator set, and moving averages (MA5 to MA200) also registering six sell readings for LENSAR shares. TradingKey moving-average signals for LNSR The same data show the stock trading between a support level around 5.28 dollars and resistance near 6.25 dollars, implying a relatively tight trading corridor for range-bound strategies.

Consensus and valuation signals

Analyst and fair-value services place LENSAR’s reference or fair value close to the prevailing market price, with one fair-value indicator listing 5.68 dollars for LNSR, only slightly above the latest traded range. MarketBeat fair value figure for LENSAR A separate valuation screening tool calculates a current price-to-earnings ratio around 2.3, which it notes is well above the stock’s recent P/E low but still below its recent high within the same metric range in the healthcare equipment and supplies group. TradingKey valuation profile for LENSAR

Within that framework, LENSAR’s valuation score ranks it in the upper third of more than 200 healthcare equipment and supplies names screened by the same provider, while its price momentum score sits in the mid-field of that peer basket. TradingKey sector ranking for LNSR For retail investors comparing the stock with larger medical device peers listed on Nasdaq and the S&P 500, the combination of a small-cap market value and a low single-digit P/E highlights a markedly different risk and growth profile versus global giants in the sector.

The laser systems behind the stock

LENSAR generates revenue with femtosecond laser platforms used in the treatment of cataracts and the management of astigmatism during cataract procedures, supplying ophthalmic surgeons with advanced imaging, planning and laser fragmentation capabilities for lens replacement workflows. Company profile overview for LENSAR

Where the shares trade today

The LENSAR shares (US52633C1071) most recently traded on Nasdaq on 2026-06-22 at about 5.64 to 5.66 U.S. dollars, implying a market capitalization in the area of 68.5 million dollars based on the latest available data.

This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. Historical data and third-party estimates are subject to revision, and investors should consult multiple sources and, where appropriate, a qualified financial adviser before making investment decisions.